News | July 16, 2007

St. Jude Gets Japanese Approval for Heart Failure Treatment Products

July 17, 2007 - St. Jude Medical Inc. today announced that it received regulatory approval from the Japanese Ministry of Health, Labor and Welfare and reimbursement approval for its first CRT-D systems to be marketed in Japan.

The two new systems used to treat heart failure patients have been approved, including the Atlas HF CRT-D (cardiac resynchronization therapy defibrillator) and the Epic HF CRT-D, which are used in conjunction with the QuickSite left-heart lead and delivered through the Apeel CS catheter delivery system.
The Atlas HF CRT-D reportedly delivers high output and tailored waveforms for patients with hearts that are difficult to defibrillate. The Epic HF CRT-D is designed for improved patient comfort.

For more information: www.sjm.com


Additional Content

News | Cardiac Resynchronization Therapy Devices (CRT)

July 21, 2025. — Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center ...

Home July 21, 2025
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

April 25, 2025 – Findings from two late-breaking clinical trials demonstrate the safety and efficacy of left bundle ...

Home April 25, 2025
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

May 22, 2023 — Findings from two new studies highlight the success of left bundle branch area pacing (LBBAP), or his ...

Home May 22, 2023
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization ...

Home May 22, 2023
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

October 27, 2021 ​​— EBR Systems Inc., developer of the world’s first wireless cardiac pacing system for heart failure ...

Home October 27, 2021
Home
Subscribe Now